0 Mid-market private equity builds on increasing investment activity

The New Zealand Private Equity and Venture Capital Monitor, released today, highlighted an increase of investment in 2015 for both private equity and venture capital markets. Mid-market investment increased to NZ$284.1m from NZ$243.5m in 2014. The average deal value at NZ$16.7m was greater than the average of NZ$12.8m in 2014. The increase in investment activity was coupled with continued strength in divestment as the portfolio companies of domestic funds sought investors for future growth.

Brad Wheeler, partner EY says ‘Venture and early stage funds invested NZ$62.5m across 69 transactions, continuing momentum from the last three years. IT and software has continued to be the dominant sector for venture activity continuing the trend of the last three years. Health and Biosciences remain at historical low levels reflecting the challenges of long lead-times and large capital requirements for innovation commercialisation.

‘The high level of mid-market activity included a mix of investment themes from international fund managers active in turnaround and secondary acquisitions from New Zealand owners. While new public listings were quiet in 2015 the market for private transactions was resilient with New Zealand owners and management wanting to see those businesses taken to their next stage.’

Total activity (investment and divestment) across all private equity and venture capital was NZ$494.4m, down from $919.5m in 2014, mainly due to there being no large buy-out deals. Large buy-out activity in 2014 was mainly driven by Pacific Equity Partners’ divestment of Griffin Foods to URC (Philippines). Total investment value was NZ$346.6m spread across 86 deals, while total divestment was lower at NZ$147.8m in 2015, down from NZ$620.3m in 2014.

Deals in 2015 included the acquisition of Manuka Health by Pacific Equity Partners, Tembusu Partners’ investment in CricHQ, Pencarrow’s investment in Icebreaker, Allegro Private Equity’s acquisition of Carpet Court and Archer Capital’s acquisition of the Aspire2 Group.

Matt Riley, chair of NZVCA says, ‘The outlook for the New Zealand PE and VC market remains positive. 2015 proved to be a successful year for mid-market divestments. This is a success oriented industry where the durability of the fund managers is wholly dependent on performance. There were no new funds raised in 2015 as managers continued building portfolios and other managers were returning capital from successful divestments. Several fund managers have announced intentions to raise new funds in 2016.’

Wheeler added, ‘For the year ahead, the PE and VC fund managers outlook remains positive, with some optimism generated by the emergence of new investor groups. EY’s latest Capital Confidence Barometer indicates a strong acquisition appetite globally with companies combining strategic M&A and cooperative alliances to navigate a complex and disruptive business landscape.’

Colin McKinnon NZVCA executive director says, `The strength of the mid-market continued in 2015. New Zealand privately owned businesses with private equity shareholders were able to execute growth aspirations by introducing new shareholders with capital and skills. Some of the new shareholders brought international capability to the New Zealand company growth trajectory.

‘Private markets and privately-owned companies continue to dominate the New Zealand business landscape. New investors have been able to access private markets through community and retirement savings platforms.
‘Kiwi founders and owners demonstrate innovation and determination that can be coupled with private capital to accelerate growth. More businesses growing makes a difference to New Zealand’s economic prospects.’


Media contact:

Colin McKinnon 0276406406
Brad Wheeler 0212285490

About the New Zealand Private Equity & Venture Capital Association
The NZVCA is a not-for-profit industry body committed to developing the Venture Capital and Private Equity industry in New Zealand. Its core objectives include the promotion of the industry and the asset class on both a domestic and international basis and working to create a world-class Venture Capital and Private Equity environment. Members include Venture Capital and Private Equity investors, financial organisations, professional advisors, academic organisations and government and quasi- government agencies.

About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organisation, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organisation, please visit

© 2016 Ernst & Young, New Zealand.
All Rights Reserved

0 Investors ponder whether Tegel can ‘do a Scales’

Tegel Group Holdings’ share sale has at least some passing similarities to that of Scales Corp, which went public in 2014, selling shares at the bottom of its range in an IPO that left its major shareholder with a significant stake. The question some investors are asking is could Tegel also over-deliver.

Scales stock has more than doubled since its 2014 initial public offering, delivering a massive gain for Kiwi private equity firm Direct Capital, which had acquired most of the company three years earlier from South Canterbury Finance for $44 million and retained a 20% stake in the IPO.

Read more

0 NZ Pharmaceuticals gets $49.6M injection

New Zealand Pharmaceuticals, which manufactures specialty chemicals, has got a $49.6 million injection from its new controlling shareholder, Australian private equity firm Archer Capital.

Last week local private equity firm Direct Capital completed the sale of its 51 percent stake in Palmerston North-based NZP for an undisclosed sum to Archer, saying it had been “very successful” for its investors.

While the price wasn’t disclosed, Australian newspapers had previously reported it as being in the realm of $200 million.

Read more

0 An ‘alarming’ proportion of KiwiSavers are confused about where they are invested

Confusion reigns among many KiwiSavers, with large numbers unsure about whether they are saving enough, or what kind of fund they are in.

In research conducted for Kiwi Wealth, the KiwiSaver scheme of Kiwibank, 781 KiwiSavers were asked about their investments.

It found nearly three-quarters of KiwiSaver members didn’t know what their KiwiSaver account might be worth when they retired.

Read more

0 Angel funds invest over $60m in 2015

Angel networks and funds invested a record $61.2 million into 94 young New Zealand companies in 2015 – a 9 percent increase on the previous record set in 2014, New Zealand Venture Investment Fund investment director Chris Twiss said today.

Releasing the latest Young Company Finance Index, Chris Twiss said New Zealand now has a strong core of investors involved in angel networks and funds which are driving the continued growth of investment into start-ups.

Read more

1 2 3 40